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Background: Patients with pancreatic tumors may have portal vein (PV) and/or superior mesenteric vein (SMV) invasion.
In such cases, lower extremity veins can provide an autogenous conduit for PV/SMV reconstruction. Little data exist,
however, describing the technique of PV/SMV reconstruction, patency of such reconstructions, and the morbidity of
using lower extremity veins for PV/SMV reconstruction during pancreaticoduodenectomy.
Methods:Thirty-four patients underwent PV/SMV reconstruction during pancreaticoduodenectomy using lower extrem-
ity vein. The saphenous vein was preferred for patching and femoral vein for replacement. We analyzed preoperative
imaging, reconstruction patency, vein harvest morbidity, and late mortality.
Results: The mean age was 62.6 years. All 34 patients had preoperative computed tomography (CT) imaging and/or
endoscopic ultrasound (EUS) scan. Fourteen of the 34 patients had evidence of PV/SMV invasion on CT or EUS scans,
14 did not, and six studies were indeterminate. Twenty-five patients had follow-up imaging, and 22 (88%) had patent
reconstructions. Fifteen patients had PV/SMV replacement using femoral vein. Seven of these 15 had minor postoper-
ative lower extremity edema that resolved over time, five had wound complications from the femoral vein harvest site,
three of which required minor operative procedures for treatment. Fifteen patients had PV/SMV patching with the great
saphenous vein, none had postoperative wound problems, and one had minimal postoperative lower extremity edema.
Four patients had PV/SMV patching using femoral vein, none had postoperative wound problems, and one had minimal
postoperative lower extremity edema. Compared with patients undergoing pancreaticoduodenectomy without PV/SMV
reconstruction, by Kaplan-Meier analysis, there was no difference in late mortality.
Conclusion: Preoperative imaging may fail to detect PV/SMV involvement in patients undergoing pancreaticoduodenec-
tomy. The PV/SMV reconstruction with leg vein provides good patency with minimal postoperative lower extremity
complications and no increase in late mortality. The lower extremities should be routinely included in the operative field
of patients undergoing pancreaticoduodenectomy. (J Vasc Surg 2010;51:662-6.)Adenocarcinoma of the pancreas is the fifth leading
cause of cancer death in the United States with 30,300 new
cases and 29,700 deaths reported in 2002.1 The manage-
ment of pancreatic tumor invasion into the lateral wall of
the portal vein (PV) or superior mesenteric vein (SMV)
represents a difficult challenge to the surgeon performing
pancreaticoduodenectomy. Invasion of the PV/SMV is
currently not a contraindication to resection as long as the
veins are patent.2 Preoperative involvement of the PV/
SMV is difficult to ascertain, and in many instances, the
vascular surgeon may be consulted intraoperatively for
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662assistance in reconstructing the PV/SMV during resection
of the tumor.
The purpose of this study was to evaluate our experi-
ence with PV reconstruction during the course of pancre-
aticoduodenectomy using either the femoral vein (FV) or
great saphenous vein (GSV). Patency of the reconstructions
was determined along with morbidity of the vein harvests
and late mortality.
PATIENTS AND METHODS
All patients undergoing PV/SMV reconstruction dur-
ing pancreaticoduodenectomy at our institution from Jan-
uary 1999 to February 2009 were identified from a pro-
spectively established vascular surgery and general surgery
registry and via Current Procedural Terminology (CPT)
codes. Institution Review Board (IRB) approval was ob-
tained before starting this study. Hospital medical records
along with vascular laboratory studies, radiologic studies,
and endoscopic ultrasound (EUS) scan studies were evalu-
ated and entered into a database. Information included
preoperative diagnosis, vein mapping studies, type of re-
construction, preoperative computed tomography (CT)
scan reports, EUS scan reports, final pathology, complica-
tions of the vein harvest, follow-up patency of the PV/SMV
reconstruction, and survival. Mortality was determined by
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death index.
In cases where PV/SMV involvement was suspected
preoperatively, veinmapping was performed to evaluate the
diameter and wall characteristics of the GSV and FVs of
both lower extremities. The technique of PV/SMV recon-
struction was dictated at the time of operation by the extent
Fig 1. A, Reconstruction using vein patch. B, Reconstruction
using a femoral vein interposition graft.of involvement of the portal vein, SMV, or PV/SMVconfluence. In general, if the involvement of the PV/SMV
was less than one-third of the circumference of the vein, the
involved portion was excised in an elliptical fashion, and a
GSV patch was placed (Fig 1, A). Patch repairs were
performed with continuous polypropylene sutures. If the
tumor involvement was more extensive (ie, greater than
one-third the circumference of the vein), then an interpo-
sition graft using FV was performed. The posterior wall of
the interposition graft was performed with interrupted 6-0
polypropylene sutures, and the anterior wall of the anasto-
mosis was performed with either interrupted or running
6-0 polypropylene sutures to avoid anastomotic purse-
stringing (Fig 1, B). The segment of vein that is patched or
replaced is usually 4-5 cm in length, and an appropriate
length of GSV or FV is harvested before resection of the
involved segment of vein. Interposition grafts were per-
formed with a moderate amount of tension, as once the
specimen is removed and the retractors are released, some
laxity on the reconstruction occurs. When interposition
grafts extended above the level of the splenic vein, the
splenic vein was selectively ligated or reconstructed de-
pending on the request of the oncologic surgeon. Recon-
struction of the splenic vein was either by reimplantation
directly into the side of the interposition graft or with an
additional piece of FV end-to-end to the splenic vein and
end-to-side to the interposition graft. Three thousand to
4000 units of heparin were given before clamping the
splanchnic veins. If necessary, an additional 1000 units of
heparin was given after 1 hour. Inflow occlusion of the
superior mesenteric artery was not utilized during clamping
of the PV, SMV, and splenic vein. The heparin was not
reversed after the reconstruction was completed.
Leg veins were harvested through continuous incisions.
If the FV was harvested, a closed suction drain was left in
place until the output was less than 40 mL/day. The FVs
were harvested from the mid to proximal thigh up to the
profunda femoris vein (Fig 2) and great saphenous veins
harvested from the saphenofemoral junction distally.
Fig 2. Femoral vein harvest.Drains were not placed after saphenous vein harvest.
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Redmond, Wash) and analyzed using statistical software
(SPSS v 17, Chicago, Ill). Independent sample t tests and
Kaplan-Meier curves were performed.
RESULTS
From January 1999 to February 2009, 34 of 323
patients (11%) undergoing pancreaticoduodenectomy at
our institution also underwent PV/SMV reconstruction
using saphenous vein or FV. Of the 34 patients who under-
went PV reconstruction for tumor adherence or invasion of
the PV/SMV, only 14 had evidence of PV/SMV involve-
ment on preoperative CT or EUS scans. Six patients were
not clear as to the involvement of the PV/SMV on preop-
erative studies, and 14 had CT scans or EUS scan studies
that were read as negative for PV/SMV tumor involve-
ment. During the pancreaticoduodenectomies, the PV was
patched in 19 cases, and interposition grafts were placed in
15 cases. The GSV was used for the patch in 15 cases and
FV in four cases where the GSV was too small. Interposi-
tion grafts were performed exclusively with FV (Fig 3).
Few complications were seen with the leg vein harvests.
Three patients required seroma drainage after an FV har-
vest and two had minor wound dehiscences after FV har-
vest. Nine patients were noted to have minimal transient
postoperative edema in the operative leg, eight who had
undergone FV harvest and one who had undergone saphe-
nous vein harvest.
Follow-up of the patients with venous duplex of the
lower extremity was not routine and was performed only
for clinical indications. There were 11 patients who had
follow-up venous duplex scan examinations of the lower
extremities. Three were found to have a deep venous
thrombosis (DVT). One of the three had thrombosis of the
vein distal to where the FV was ligated at an examination
performed 2 years after the vein was harvested. Two pa-
tients were found to have ipsilateral DVT proximal to the
ligation of the FV. Both of these patients also had leg
Fig 3. Superior mesenteric vein reconstruction with an interpo-
sition femoral vein graft. The vessel loop is around the splenic vein.edema and both required seroma drainage.The final pathology in 27 of the 34 patients with PV/
SMV reconstruction was adenocarcinoma. Mean survival for
all 34 patients was 26.2  5.7 months. The median survival
for all 34 patients was 17.3 3.0months. Themajority of the
patients (n 22, 65%) underwent the operation more than 2
years before this study with 10 patients undergoing pancreati-
coduodenectomy with PV/SMV reconstruction over 4 years
before the study. Kaplan-Meier curves comparing survival in
patients with pancreatic adenocarcinoma, with and without
PV/SMV reconstruction, were not statistically different (P
.17; Fig 4). However, survival for all patients with adenocar-
cinoma was worse than that for those without adenocarci-
noma (P .007; Fig 5).
Follow-up imaging studies were selectively performed
Fig 4. Kaplan-Meier curves for patient survival after pancreati-
coduodenectomy in patients with adenocarcinoma of the pancreas
with (green line) and without (blue line) reconstruction of the
portal or superior mesenteric veins.
Fig 5. Kaplan-Meier curves for patient survival after pancreati-
coduodenectomy in patients with (green line) and without (blue
line) adenocarcinoma of the pancreas.at the discretion of the oncologic surgeon and primarily to
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follow-up imaging studies. The mean time to imaging
studies was 5 months  7 months (range, 5-792 days).
Twenty-two of the 25 studies (88%) showed patency of the
PV/SMV reconstruction. Two patients occluded their in-
terposition graft within 3 weeks after undergoing pancre-
aticoduodenectomy. These two patients survived their hos-
pitalization, but death was at 80 days in one patient and
130 days in the other. One additional patient with muci-
nous noncystic carcinoma developed eventual extrinsic
compression and occlusion of the PV/SMV reconstruction
at 200 days postoperatively from recurrence of disease but
was still alive at 783 days postoperatively.
DISCUSSION
A PV/SMV reconstruction with either patch veno-
plasty or an interposition vein graft is a viable option to
facilitate pancreaticoduodenectomy when there is sus-
pected tumor invasion or adhesion to the PV/SMV. Previ-
ous studies, in addition to ours, have shown that survival
after pancreaticoduodenectomy for pancreatic cancer, with
reconstruction of the PV/SMV, is similar to patients un-
dergoing pancreaticoduodenectomy for pancreatic cancer
with no PV/SMV invasion. Fuhrman et al3 reported 23
patients with localized invasion of the PV/SMV confluence
that required resection and reconstruction to complete the
pancreaticoduodenectomy. There was no difference in me-
dian survival when compared with 36 control patients who
did not require PV/SMV reconstruction. In a follow-up
study, the authors report 31 patients who required resec-
tion of the PV/SMV confluence along with the pancreatic
resection. These patients were compared with 44 controls
(patients undergoing standard pancreaticoduodenectomy
without PV/SMV reconstruction). Again, no difference in
survival was noted. The authors suggest venous invasion is
more a marker of tumor location and not a marker of tumor
aggressiveness.4 In another large study, Tseng et al5 evalu-
ated survival in 126 patients who underwent PV/SMV
reconstruction after pancreaticoduodenectomy using inter-
nal jugular vein. They also found that properly selected
patients with adenocarcinoma of the pancreatic head who
require venous reconstruction have a median survival that
does not differ from those that undergo a standard pancre-
aticoduodenectomy.
In our study, there was also no statistical difference in
survival in the patients undergoing pancreaticoduodenec-
tomy for pancreatic cancer with and without PV/SMV
reconstruction. However, the overall number of patients
requiring PV/SMV reconstruction to facilitate a Whipple
resection for cancer is relatively small in any series. Dog-
matic conclusions regarding equal survival of patients un-
dergoing PV/SMV reconstruction during pancreaticoduo-
denectomy are probably not warranted at this time. It does,
however, seem they do not do dramatically worse than
those patients not requiring PV/SMV reconstruction. This
would seem a fertile area for a meta-analysis of the available
literature on this subject.The type and extent of PV/SMV reconstruction during
pancreaticoduodenectomy is dependent upon the extent of
involvement of the SMV and PV. In cases where the tumor
involves only a portion of the wall of the PV/SMV, the
involved portion can be excised in an elliptical fashion and
reconstruction of the PV/SMV achieved with a vein
patch.6 It is our opinion that this requires less than one-
third of the vessel circumference to be involved. In the
event that a greater degree of vessel involvement is found,
we believe reconstruction is best achieved with placement
of an interposition graft using a reversed FV graft.
There have been studies using polytetrafluoroethylene
for PV/SMV reconstruction.7 However, the poor durabil-
ity and increased risk of infection have made the autoge-
nous vein graft the preferred material for reconstruction.
Autogenous PV/SMV reconstruction has previously been
reported primarily using internal jugular vein as the venous
conduit. Use of FV8 and the left renal vein9 has also been
reported, although to our knowledge, this is the largest
series employing lower extremity veins.
The PV/SMV involvement with tumor can sometimes
be determined preoperatively. The CT scan findings such as
PV or SMV narrowing, PV wall irregularity, or circumfer-
ential involvement of the PV 90 degrees raise the suspi-
cion of tumor involvement.10 An EUS scan can also be
utilized to help identify PV involvement. Findings of irreg-
ular venous walls, loss of interface, and proximity of the
tumor mass can also raise the suspicion of PV involve-
ment.11 An EUS scan, however, is rather insensitive for
detecting SMV involvement. The specificities of the preop-
erative imaging studies increase as the number of pertinent
findings increase. However, the sensitivities of these studies
remain marginal at best.
The lower extremities can be easily prepped into the
sterile field. We believe this should be routine for pancre-
aticoduodenectomy, as many times preoperative imaging
studies do not adequately demonstrate tumor adherence or
invasion of the PV/SMV. In fact, only 14 of the 34 patients
in this series had suspected PV/SMV involvement with
preoperative endoscopic ultrasound scan or CT scanning.
Routine prepping of the lower extremities for pancreati-
coduodenectomy will avoid the inconvenience of having to
prepare a new sterile field for harvest of a venous conduit,
should PV/SMV reconstruction unexpectedly become re-
quired. Once the anatomy is visualized, and suspected
tumor adhesion or invasion of the PV/SMV identified, the
lower extremities can easily be positioned for harvest of the
GSV or FV without the need to reposition the mechanical
retractors already in place for the pancreaticoduodenec-
tomy. Because many times the venous reconstruction can
be achieved with a vein patch rather than an interposition
graft, prepping the lower extremities into the field allows
use of the GSV for the venous reconstruction, avoiding
harvest of a major vein such as the internal jugular vein or
left renal vein.
When PV/SMV reconstruction is anticipated preoper-
atively, the suitability of the FV and GSV to serve as a
venous conduit or patch can be determined with ultra-
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quate diameter and length. In such cases, it is then neces-
sary to prepare only the lower extremity with the best
potential venous conduits into the operative field.
The FV is a very versatile conduit for vascular recon-
structions. Although it does not elongate under arterial
pressure like a saphenous vein and is a bit tedious to harvest,
it is a very useful conduit for arterial and venous reconstruc-
tions. Among other indications, in our practice, in addition
to using FV for PV/SMV reconstruction, we have used FV
as a replacement for infected lower extremity and intra-
abdominal prosthetic grafts, as a replacement for the com-
mon carotid artery during resection of head and neck
tumors, for splanchnic artery reconstruction in the setting
of bowel infarction, and for reconstruction of traumatic
intra-abdominal vascular injuries when there is concomi-
tant bowel injury.
There is little in the way of reported harvest-related
complications of the FV as long as the profunda femoris
vein is preserved and the harvest does not extend into the
popliteal fossa.12 Morbidity related to harvest of lower
extremity veins was also acceptable in this series with no
severe cases of postoperative edema and minimal need for
operative intervention to treat a harvest site wound com-
plication. There were, however, three cases of known DVT
in this series. Although one of these was below the harvest
site and not diagnosed until 2 years postoperatively, it may
be prudent to perform routine postoperative surveillance
venous ultrasound scan studies after FV harvest.
Survival after PV/SMV reconstructions is routinely
reported but patency is not. Patency does, however, seem
to be quite good. In our study, patency was excellent in
patients with follow-up imaging studies. Twenty-five pa-
tients had follow-up imaging studies at a mean of 5 months
 7 months (range, 5-792 days), and 22 had patent recon-
structions. Perioperatively occluded reconstructions were
likely due to technical errors with kinking of an interposi-
tion graft, clearly the etiology in one of the two early
occlusions.
CONCLUSIONS
A PV/SMV reconstruction with either GSV or FV is a
viable option during pancreaticoduodenectomy. In this
study, we have shown good patency of the reconstructions
with minimal morbidity from the harvest sites. Lower ex-
tremities should be prepared within the operative field for
possible GSV or FV use during pancreaticoduodenectomy.AUTHOR CONTRIBUTIONS
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